Last Updated: 31-07-2025 | Format: PDF | Report ID:20243 | Author: Ankita R
| Key Market Question | Answer |
|---|---|
| What is the market size in 2025? | $7,150 Million |
| What is the projected market size by 2035? | $12,500 Million |
| What is the market CAGR from 2025 to 2035? | 5.7% |
| Which region dominates the market? | US (73%) |
| Which product/service type dominates the market? | Flow Cytometry (36%) |
| Which application leads the market? | Drug Discovery (33%) |
| Who are the major buyers? | Pharma & Biotech (47%), Academic/Research (28%) |
| What are the key market growth drivers? | Rapid advancements in high-throughput cell analysis technologies; Increasing prevalence of chronic diseases and demand for personalized medicine have led to higher investments in cell analysis platforms |
| What are the major market challenges? | Complexity in integrating disparate cell analysis technologies and achieving seamless data interoperability poses challenges for multi-center studies; High capital investment required for advanced instrumentation and skilled personnel shortages continue to limit adoption in smaller laboratories and hospitals |
| What is the forecast period? |
Study period:
2020-2035
Base year:
2026
Historical data
2020-2024
NO OF PAGE:
167
What You Get:
| 2026–2035 |
| Who are the key market players? | Thermo Fisher Scientific Inc., Becton, Dickinson and Company, Danaher Corporation, Merck KGaA, Agilent Technologies, PerkinElmer Inc., Bio-Rad Laboratories, Inc., GE Healthcare, Olympus Corporation, Promega Corporation, Miltenyi Biotec, Sartorius AG, Charles River Laboratories, Bio-Techne Corporation, Sysmex Corporation |
Global Residual DNA Testing Market: by Type (qPCR-based Residual DNA Testing, PCR-based Residual DNA Testing, DNA Hybridization, ELISA-based Residual DNA Testing, Others), Application (Biopharmaceuticals, Vaccines, Gene Therapy, Cell Therapy, Blood and Plasma Products, Others), Distribution Channels (Direct Sales, Distributors, Online Sales, Others), Technology (qPCR, PCR, Hybridization, ELISA, Capillary Electrophoresis, Others), Organization Size (Small, Medium, Large) and By Global – Historical & Forecast Period (2020-2035) Comprehensive Study 2025
Global Stem Cell Therapy Market Market: by Type (Allogeneic, Autologous), Application (Musculoskeletal Disorders, Wounds & Injuries, Cardiovascular Diseases, Surgeries, Gastrointestinal Diseases, Other Applications), Distribution Channels (Hospitals, Clinics, Academic & Research Institutes, Contract Research Organizations, Direct Sales, Online Channels), Technology (Stem Cell Acquisition, Stem Cell Preservation, Expansion, Sub-culture, Cryopreservation, Other Technologies), Organization Size (Small, Medium, Large) and By Global – Historical & Forecast Period (2020-2035) Comprehensive Study 2025
North America Human Identification Market Market: by Type (DNA Analysis, Biometric Analysis, Facial Recognition, Fingerprint Analysis, Iris Recognition, Voice Recognition) Application (Forensic Applications, Paternity Testing, Disaster Victim Identification, Population Genetics, Wildlife Forensics, Others), Distribution Channels (Online, Offline, Direct Sales, Distributors, Resellers, Others), Technology (Polymerase Chain Reaction (PCR), Next-Generation Sequencing (NGS), Capillary Electrophoresis, Automated Fingerprint Identification, Digital Imaging, Others), Organization Size (Small, Medium, Large) and By North America Historical & Forecast Period (2020-2035) Comprehensive Study 2025
North America Newborn Screening Market: by Type (Blood Tests, Hearing Screening, Pulse Oximetry, Genetic Testing, Critical Congenital Heart Disease Screening, Other Types), Application (Dry Blood Spot Screening, Hearing Screening, Cystic Fibrosis, Sickle Cell Disease, Critical Congenital Heart Disease, Other Applications), Distribution Channels (Hospitals, Diagnostic Centers, Clinics, Laboratories, Specialty Centers, Other Distribution Channels), Technology (Tandem Mass Spectrometry, Immunoassays & Enzymatic Assays, Pulse Oximetry, Molecular Assays, Hearing Screening Technology, Other Technologies), Organization Size (Small, Medium, Large) and By North America Historical & Forecast Period (2020-2035) Comprehensive Study 2025
North America Cell & Gene Therapy Manufacturing Services Market: by Type (Allogeneic, Autologous, Viral Vector, Non-viral Vector, Plasmid DNA, Others), Application (Oncology, Cardiovascular Diseases, Neurological Disorders, Rare Diseases, Infectious Diseases, Others), Distribution Channels (Direct Tenders, Third-Party Distributors, Online Platforms, Others), Technology (Gene Editing, Cell Expansion, Viral Vector Production, Cryopreservation, Automation, Others), Organization Size (Small, Medium, Large) and By North America Historical & Forecast Period (2020-2035) Comprehensive Study 2025